PetMed Express, Inc. (NASDAQ:PETS - Get Free Report) crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $3.87 and traded as high as $4.36. PetMed Express shares last traded at $4.22, with a volume of 262,598 shares.
Wall Street Analyst Weigh In
Separately, Lake Street Capital reaffirmed a "hold" rating and issued a $3.50 target price (down previously from $7.00) on shares of PetMed Express in a report on Wednesday, August 7th.
Check Out Our Latest Analysis on PetMed Express
PetMed Express Stock Performance
The company's 50 day moving average is $3.81 and its 200 day moving average is $3.88. The stock has a market capitalization of $118.04 million, a price-to-earnings ratio of -33.71 and a beta of 0.68.
PetMed Express (NASDAQ:PETS - Get Free Report) last announced its quarterly earnings data on Tuesday, August 6th. The company reported $0.18 EPS for the quarter, beating analysts' consensus estimates of ($0.12) by $0.30. PetMed Express had a negative net margin of 1.24% and a negative return on equity of 3.44%. The business had revenue of $67.95 million during the quarter, compared to analyst estimates of $77.52 million. On average, equities research analysts anticipate that PetMed Express, Inc. will post 0.08 earnings per share for the current fiscal year.
Insider Buying and Selling at PetMed Express
In other news, major shareholder Nina Capital Holdings Inc. acquired 12,500 shares of the firm's stock in a transaction dated Monday, September 9th. The shares were bought at an average price of $3.34 per share, with a total value of $41,750.00. Following the acquisition, the insider now owns 2,078,000 shares of the company's stock, valued at $6,940,520. This trade represents a 0.00 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 1.10% of the company's stock.
Hedge Funds Weigh In On PetMed Express
A number of large investors have recently modified their holdings of the stock. Point72 DIFC Ltd acquired a new position in PetMed Express during the second quarter valued at approximately $34,000. SG Americas Securities LLC bought a new stake in shares of PetMed Express in the second quarter valued at approximately $46,000. Marshall Wace LLP acquired a new stake in shares of PetMed Express during the 2nd quarter worth $46,000. Pinnacle Wealth Planning Services Inc. bought a new position in PetMed Express in the 1st quarter valued at about $61,000. Finally, Legacy Advisors LLC acquired a new position in PetMed Express during the second quarter valued at approximately $96,000. 73.33% of the stock is currently owned by institutional investors and hedge funds.
PetMed Express Company Profile
(
Get Free Report)
PetMed Express, Inc, together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.
Featured Articles
Before you consider PetMed Express, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and PetMed Express wasn't on the list.
While PetMed Express currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
